Is NovaBay Pharmaceuticals financially healthy?
Not really
NovaBay Pharmaceuticals carries heavy debt: it would take 3.4 years of earnings to pay it off.
The numbers behind it
Net debt / EBITDA3.4 years
Current ratio5.3×Short-term assets for each $1 of bills due within a year
Interest coverage-18.8×How many times operating profit covers the interest bill
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about NovaBay Pharmaceuticals
Data as of Jun 8, 2026.